A label can say almost anything. It can name a peptide, print a sequence, list a molecular weight — but a printed claim isn't the same as proof. Because research-grade peptides are sold strictly for research use only, the work of any serious lab starts with a deceptively simple question: how do we actually know the molecule in the vial is the one on the label? The answer, more often than not, is mass spectrometry. This article walks through how peptide mass spectrometry sequence verification works — how a peptide becomes a flying ion, breaks into readable fragments, and gets matched against what its sequence predicts — and why researchers trust a convergence of methods over any single readout.
Why Confirming a Peptide Sequence Matters
Start by separating two ideas that blur together easily: mass and sequence. Mass is the total weight of the molecule. Sequence is the exact order of amino acids strung along the chain. They're related, but they aren't the same claim — and that gap is where a lot of analytical care lives.
Here's why mass alone falls short. Two peptides built from the same amino acids in a different order weigh exactly the same. Swap two residues and the total mass doesn't budge, yet the molecule is, for any practical purpose, something else entirely. Measuring mass narrows the field of possibilities. It can't, by itself, prove the order of the residues. Identity — the real claim a label makes — is a statement about sequence.
This is also why sequence confirmation sits upstream of everything else. A purity figure on a certificate of analysis tells you how much of the sample is the intended molecule versus everything else, but that's a different question than identity. Purity means nothing if the "intended molecule" itself was never confirmed. Get identity wrong and every downstream number — purity, stability, assay results — describes the wrong thing.
Two Ways In — MALDI vs ESI Ionization
Before a mass spectrometer can weigh anything, the peptide has to become a gas-phase ion. The instrument measures the mass-to-charge ratio of charged particles moving through a vacuum, so a solid or dissolved peptide is useless to it until it carries a charge and is airborne. Two ionization techniques dominate peptide work, and they get there by very different routes.
MALDI: a matrix and a laser pulse
Matrix-assisted laser desorption/ionization mixes the peptide into a crystallized chemical "matrix" that soaks up light. A laser pulse hits the spot, the matrix flashes that energy into the sample, and peptide ions lift off into the instrument. MALDI is robust, tolerates a fair amount of sample complexity, and tends to produce predominantly singly charged ions — one charge per molecule — which keeps the resulting spectra easy to read. That simplicity is part of why MALDI pairs so naturally with fingerprinting workflows.
ESI: spraying ions out of solution
Electrospray ionization takes the opposite approach. The peptide stays in solution and is sprayed through a charged needle into a fine mist, the solvent evaporating away until bare ions remain. ESI tends to produce multiply charged ions, and it couples cleanly to liquid chromatography, so a complex mixture can be separated and ionized in one continuous flow. As one comparison of the two methods notes, ESI ionizes analytes from solution and favors sequence determination, while MALDI produces predominantly singly charged ions. The two are complementary rather than competing — a theme that returns at the end of this article.
Reading the Ladder — b-ions and y-ions
Weighing an intact peptide gives you its mass. Reading its sequence is another matter: you have to break it apart in a controlled way and weigh the pieces. Give a peptide ion a jolt of energy and it tends to snap along the backbone, at the amide bonds linking one amino acid to the next. What's left is a nested set of fragments, each one a residue longer than the last.
What the fragments are called
Fragment-ion spectra consist mainly of two families. As a classic proteomics study describes it, b-ions retain the charge on the amino-terminal fragment and are indexed from left to right along the sequence, while y-ions retain the charge on the carboxy-terminal fragment and are indexed in the opposite direction. In plain terms: b-ions count up the sequence from one end, y-ions count up from the other. Because they read from opposite directions, the two series cross-check each other.